You just read:

Small but Valuable: How Unmet Need in the Severe Asthma Market is Driving Nucala Sales and Offers Opportunity for Others, Including, Teva, AstraZeneca, Sanofi, and Regeneron

News provided by

Decision Resources Group

15 Mar, 2017, 10:05 ET